425: Israel Acquisitions Corp. Faces Nasdaq Delisting

Israel Acquisitions Corp. (ISRL) received a delist determination from Nasdaq for failing to meet the minimum market value requirement, with its securities set to move to OTC Markets while the company pursues its business combination.

Summary

• Israel Acquisitions Corp. (ISRL) received a delist determination letter from Nasdaq on November 25, 2025, for failing to comply with Nasdaq Listing Rule 5450(b)(2)(A).
• The company did not maintain a minimum market value of listed securities of at least $50 million for the previous 30 consecutive business days, a requirement it was notified of on May 28, 2025.
• Unless an appeal is filed by December 2, 2025, ISRL's securities will be delisted on December 4, 2025.
• Following delisting, the company's common stock, units, and warrants (ISRL, ISRLU, ISRLW) will be eligible to trade on the OTC Markets.
• Despite the delisting, the company intends to complete its previously announced business combination with Gadfin Ltd., with Gadfin Regev Holdings Ltd. (NewPubco) serving as the combined company.
• The company and Gadfin plan to apply to have NewPubco's securities listed on Nasdaq following the consummation of the Business Combination.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the imminent delisting from Nasdaq, which implies significant operational and market challenges. However, the company's stated intention to complete its business combination and seek a future Nasdaq listing for the combined entity offers a glimmer of potential recovery, preventing a 'strong sell' rating.

Positives

• The company maintains its intention to complete the announced business combination with Gadfin Ltd.
• The combined company, Gadfin Regev Holdings Ltd. (NewPubco), plans to apply for listing on Nasdaq following the consummation of the Business Combination.

Negatives

• The company's securities will be delisted from The Nasdaq Stock Market LLC due to non-compliance with the minimum market value of listed securities requirement.
• Trading on the OTC Markets may result in a very limited market, adversely affecting the trading price of the company's securities.
• There is no assurance that securities will continue to trade on OTC Markets, that broker-dealers will provide public quotes, or that trading volume will be sufficient for an efficient market.

Risks

• The company's securities will be delisted from Nasdaq, potentially leading to reduced liquidity and an adverse impact on trading price.
• Trading on the OTC Markets may be limited, and there is no guarantee of continued trading, broker-dealer quotes, or sufficient trading volume.
• Risks associated with the timing of the closing of the proposed business combination, including conditions not being satisfied or waived, or the transaction not occurring.
• The outcome of any legal proceedings that may be instituted against the parties related to the proposed transactions.
• The occurrence of any event, change, or circumstance that could lead to the termination of the proposed business combination.
• Uncertainty regarding the combined company's ability to secure a Nasdaq listing post-business combination.

Future Outlook

The company intends to proceed with its business combination with Gadfin Ltd. and expects the combined entity, Gadfin Regev Holdings Ltd. (NewPubco), to apply for a Nasdaq listing after the merger is completed. Its current securities will be eligible to trade on the OTC Markets following delisting from Nasdaq.

Management Comments

• The company remains committed to completing the announced business combination with Gadfin Ltd. as described in its Current Report on Form 8-K filed on January 27, 2025.
• The company and Gadfin plan to apply to have NewPubco's securities listed on Nasdaq following the consummation of the Business Combination.

Industry Context

This announcement highlights a common challenge for Special Purpose Acquisition Companies (SPACs) that fail to maintain listing requirements or complete their de-SPAC transactions within specified timelines. Delisting to OTC Markets is a typical consequence, often leading to reduced liquidity and investor interest. The continued pursuit of the business combination, with an aim to relist the combined entity, reflects a strategic effort to salvage value despite the current setback.

Stakeholder Impact

• Shareholders will experience the delisting of securities from Nasdaq, potentially leading to reduced liquidity and an adverse impact on the trading price.
• Shareholders will face uncertainty regarding the future trading environment on the OTC Markets and the successful completion and subsequent Nasdaq listing of the business combination.

Next Steps

• The company has until December 2, 2025, to request a hearing panel appeal of the delist determination.
• If no appeal is made, Nasdaq will complete the delisting by filing a Form 25-NSE with the SEC after applicable review and appeal periods.
• The company's securities will become eligible to trade on the OTC Markets following suspension from Nasdaq.
• The company intends to complete the business combination with Gadfin Ltd.
• The combined company (NewPubco) plans to apply for listing on Nasdaq after the business combination is consummated.

Key Dates

Recommendation

The recommendation is 'hold' for existing shareholders due to the immediate negative impact of Nasdaq delisting and the associated risks of reduced liquidity and price volatility on the OTC Markets. However, the company's stated commitment to completing the business combination with Gadfin and the intention to relist the combined entity on Nasdaq provides a potential long-term upside. For new investors, the current situation presents high speculative risk. Existing shareholders should monitor the progress of the business combination and the appeal process closely before making further decisions.

Keywords

Israel Acquisitions Corp, ISRL, Nasdaq delisting, SPAC, business combination, Gadfin Ltd, OTC Markets, market value, securities, Form 425